Time and geographical variations in utilization of endocrine therapy for breast cancer in Australia
Abstract:Background: Endocrine therapies, aromatase inhibitors and tamoxifen, are commonly used as an adjuvant treatment in women with breast cancer.
Document Type: Research Article
Affiliations: 1: Quality Use of Medicines and Pharmacy Research Centre, Sansom Institute 2: School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, South Australia, Australia
Publication date: 2011-02-01